Questions we get every week.

A 503A is a state-licensed compounding pharmacy authorized to prepare medications for specific patients under a valid prescription. It is different from a 503B outsourcing facility. Our partner is audited annually and maintains USP-797 sterile compounding certification.

Currently US-only, in all 50 states. We are not licensed in Alabama, Arkansas, or Hawaii. We plan Canadian availability in 2027 pending Health Canada review.

Median 6 business days: intake → clinician review (48 hr) → compounding (24 hr) → cold-chain ship (2-3 days). If you need labs pulled, add 3-5 days for lab turnaround.

In a discreet unbranded carton with insulated liner and cold packs to maintain 2–8 °C. Signature required on delivery. Includes vial(s), bacteriostatic water, 29G insulin syringes, alcohol wipes, sharps container, and a printed dosing chart.

Yes, any time. Edit, pause, or cancel from your patient portal — no fee, no friction. Dose changes require clinician review (turnaround ~48 hours).

Unopened lyophilized: refrigerated at 2–8 °C, stable to expiry on label. Reconstituted: refrigerated, stable 30 days. Do not freeze reconstituted solution.

Lyophilized (powder) vials tolerate brief room-temperature excursions. Reconstituted vials are more sensitive — if it sat out > 12 hours warm, message your clinician before using. We will replace at no charge in most cases.

Not directly. We can provide an itemized superbill for patients to submit to their insurer or HSA/FSA. GLP-1 agonists (semaglutide, tirzepatide) may qualify for reimbursement depending on your plan.

Unopened, unshipped orders: full refund. Compounded medications cannot be returned per state pharmacy law, but if something is wrong with your shipment (wrong product, temperature excursion, damage), we replace it at no charge.